Recent advances in genomics have allowed us to begin addressing the genetic basis of stroke at molecular level. These advances are especially important for clinical diagnosis and therapy of stroke caused by monogenic variation, and they may even lead to a revolutionary treatment for these patients. In this review, we summarized the current status of genetic research in ischemic stroke, hoping to provide guidance for clinicians in clinical practice.